A novel algorithm for cardiovascular screening using conjunctival microcirculatory parameters and blood biomarkers

Agnes Awuah1, Julie S Moore1, M Andrew Nesbit1

  • 1Biomedical Sciences Research Institute, Ulster University, Cromore Road, Coleraine, BT52 1SA, UK.

Scientific Reports
|April 22, 2022
PubMed

Insights

A new algorithm combining conjunctival blood vessel analysis and biomarkers shows promise for screening coronary artery disease (CAD). This non-invasive method could aid in early detection of CAD.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Medical Diagnostics

Background:

  • Microvascular haemodynamic alterations are linked to coronary artery disease (CAD).
  • The conjunctival microcirculation offers a non-invasive assessment method.
  • Previous studies have not explored conjunctival microcirculation for CAD identification algorithms.

Purpose of the Study:

  • To investigate the utility of conjunctival microcirculation in identifying patients with CAD.
  • To develop and evaluate a novel algorithm for CAD screening using conjunctival haemodynamics and biomarkers.

Main Methods:

  • A case-control study involving 66 post-myocardial infarction patients and 66 healthy controls.
  • Assessment of conjunctival microcirculation haemodynamics using an iPhone and slit lamp imaging tool.
  • Analysis of haemodynamic properties with semi-automated software and comparison between groups.
  • Integration of conjunctival parameters with biomarkers (N-terminal pro-brain natriuretic peptide, adiponectin).

Main Results:

  • The developed algorithm, combining conjunctival blood velocity and biomarkers, achieved an AUROC of 0.967.
  • The algorithm demonstrated high sensitivity (93.0%) and specificity (91.5%) for detecting CAD.
  • Conjunctival microcirculatory parameters and specific blood biomarkers were significant predictors.

Conclusions:

  • A novel algorithm integrating conjunctival haemodynamics and blood biomarkers shows potential as a non-invasive screening tool for CAD.
  • This approach could be valuable for early detection, particularly in asymptomatic individuals.
  • Further validation is recommended for clinical utility in broader populations.